Review and uses of stereotactic body radiation Therapy for oligometastases

Oncologist

Volumn 17, Issue 8, 2012, Pages 1100-1107

  Alongi, Filippo ^a   Arcangeli, Stefano ^a   Filippi, Andrea Riccardo ^b   Ricardi, Umberto ^b   Scorsetti, Marta ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Health care economics; Image guided; Metastases; Neoplasm; Radiotherapy

Indexed keywords

ADRENAL INSUFFICIENCY; ADRENAL METASTASIS; CANCER CHEMOTHERAPY; COLORECTAL CANCER; CONE BEAM COMPUTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DUODENUM ULCER; FATIGUE; GASTROINTESTINAL TOXICITY; HUMAN; LIVER DISEASE; LIVER METASTASIS; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; METASTASIS; NAUSEA; OLIGOMETASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIOBIOLOGY; RADIOFREQUENCY ABLATION; REVIEW; SPINAL CORD METASTASIS; STEREOTACTIC BODY RADIATION THERAPY; TOXICITY; TREATMENT OUTCOME; TUMOR VOLUME; UROGENITAL TRACT DISEASE;

ADRENAL GLAND NEOPLASMS; CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; DOSE FRACTIONATION; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPH NODES; RADIOSURGERY; SPINAL NEOPLASMS;

EID: 84865270338     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2012-0092     Document Type: Review

References (78)

1. Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol 2011;8:378-382.
2. Rubin P, Brasacchio R, Katz A. Solitary metastases: Illusion versus reality. Semin Radiat Oncol 2006;16: 120-130.
3. Yu CX, Amies CJ, Svatos M. Planning and delivery of intensity-modulated radiation therapy. Med Phys 2008;35:5233-5241.
4. Welsh JS. Basics of particle therapy: Introduction to hadrons. Am J Clin Oncol 2008;31:493-495.
5. Onimaru R, Shirato H, Shimizu S et al. Tolerance of organs at risk in small volume, hypofractionated, imageguided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 2003;56:126-135.
6. Norihisa Y, Nagata Y, Takayama K et al. Stereotactic body radiotherapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys 2008;72:398-403.
7. Nagata Y, Wulf J, Lax I et al. Stereotactic radiotherapy of primary lung cancer and other targets: Results of consultant meeting of the International Atomic Energy Agency. Int J Radiat Oncol Biol Phys 2011;79:660-669.
8. Boda-Heggemann J, Lohr F, Wenz F et al. kV conebeam CT-based IGRT: A clinical review. Strahlenther Onkol 2011;187:284-291.
9. Chang BK, Timmerman RD. Stereotactic body radiation therapy: A comprehensive review. Am J Clin Oncol 2007;30:637-644.
10. Lo SS, Cardenes HR, Teh BS et al. Stereotactic body radiation therapy for nonpulmonary primary tumors. Expert Rev Anticancer Ther 2008;8:1939-1951.
11. Fuks Z, Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell 2005;8:89-91.
12. Hall EJ, Brenner DJ. The radiobiology of radiosurgery: Rationale for different treatment regimes for AVMs and malignancies. Int J Radiat Oncol Biol Phys 1993;25:381-385.
13. Siva S, MacManus M, Ball D. Stereotactic radiotherapy for pulmonary oligometastases: A systematic review. J Thorac Oncol 2010;5:1091-1099.
14. Rusthoven KE, Kavanagh BD, Burri SH et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009;27:1579-1584.
15. Lax I, Blomgren H, LarsonDet al. Extracranial stereotactic radiosurgery of localized targets. J Radiosurg 1998;1:135-148.
16. Blomgren H, Lax I, Näslund I, et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator: Clinical experience of the first thirty-one patients. Acta Oncol 1995;34:861-870.
17. Ricardi U, Filippi AR, Guarneri A, et al. Stereotactic body radiation therapy for lung metastases. Lung Cancer 2012;75:77-81.
18. Okunieff P, Petersen AL, Philip A et al. Stereotactic body radiation therapy (SBRT) for lung metastases. Acta Oncol 2006;45:808-817.
19. The International Registry of Lung Metastases. Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 1997;113:37-49.
20. Lencioni R, Crocetti L, Cioni R et al. Response to radiofrequency ablation of pulmonary tumours: A prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008;9:621-628.
21. Lo SS, Fakiris AJ, Chang EL et al. Stereotactic body radiation therapy: A novel treatment modality. Nat Rev Clin Oncol 2010;7:44-54.
22. Scorsetti M, Bignardi M, Alongi F et al. Stereotactic body radiation therapy for abdominal targets using volumetric intensity modulated arc therapy with Rapid-Arc: Feasibility and clinical preliminary results. Acta Oncol 2011;50:528-538.
23. Kavanagh BD, McGarry RC, Timmerman RD. Extracranial radiosurgery (stereotactic body radiation ther-apy) for oligometastases. Semin Radiat Oncol 2006;16: 77-84.
24. Chawla S, Chen Y, Katz AW et al. Stereotactic body radiotherapy for treatment of adrenal metastases. Int J Radiat Oncol Biol Phys 2009;75:71-75.
25. Oshiro Y, Takeda Y, Hirano S et al. Role of radiotherapy for local control of asymptomatic adrenal metastasis from lung cancer. Am J Clin Oncol 2011;34:249-253.
26. Casamassima F, Livi L, Masciullo S et al. Stereotactic radiotherapy for adrenal gland metastases: University of Florence experience. Int J Radiat Oncol Biol Phys 2012;82:919-923.
27. Choti MA, Sitzmann JV, Tiburi MF et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002;235:759-766.
28. Wong SL, Mangu PB, Choti MA et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 2010;28:493-508.
29. Lawrence TS, Robertson JM, Anscher MS et al. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 1995;31:1237-1248.
30. Lo SS, Fakiris AJ, Teh BS et al. Stereotactic body radiation therapy for oligometastases. Expert Rev Anticancer Ther 2009;9:621-635.
31. Blomgren H, Lax I, GöransonHet al. Radiosurgery for tumors in the body: Clinical experience using a new method. J Radiosurg 1998;1:63-74.
32. Wulf J, Hädinger U, Oppitz U et al. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 2001;177:645-655.
33. Sato M, Uematsu M, Yamamoto F. Feasibility of frameless stereotactic high-dose radiation therapy for primary and metastatic liver cancer. J Radiosurg 1998;1:233-238.
34. Katz AW, Carey-Sampson M, Muhs AG et al. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys 2007;67:793-798.
35. Wada H, Takai Y, Nemoto K et al. Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated highdose radiotherapy for small pulmonary or hepatic tumors. Int J Radiat Oncol Biol Phys 2004;58:1114-1120.
36. Gunvén P, Blomgren H, Lax I et al. Curative stereotactic body radiotherapy for liver malignancy. Med Oncol 2009;26:327-334.
37. Herfarth KK, Debus J, Lohr F et al. Stereotactic single-dose radiation therapy of liver tumors: Results of a phase I/II trial. J Clin Oncol 2001;19:164-170.
38. Herfarth KK, Hof H, Bahner ML et al. Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int J Radiat Oncol Biol Phys 2003;57:444-451.
39. Hoyer M, Roed H, Traberg Hansen A et al. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 2006;45:823-830.
40. Kavanagh BD, Schefter TE, Cardenes HR et al. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol 2006;45:848-855.
41. Schefter TE, Kavanagh BD, Timmerman RD et al. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 2005;62:1371-1378.
42. Lee MT, Kim JJ, Dinniwell R et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 2009;27:1585-1591.
43. Méndez Romero A, Wunderink W, Hussain SM et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase I-II study. Acta Oncol 2006;45:831-837.
44. Rusthoven KE, Kavanagh BD, Cardenes H et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009;27:1572-1578.
45. Goodman KA, Wiegner EA, Maturen KE et al. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys 2010;78:486-493.
46. Rule W, Timmerman R, Tong L et al. Phase I doseescalation study of stereotactic body radiotherapy in patients with hepatic metastases. Ann Surg Oncol 2011;18: 1081-1087.
47. Choi CW, Cho CK, Yoo SY et al. Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer. Int J Radiat Oncol Biol Phys 2009;74:147-153.
48. Jereczek-Fossa BA, Fariselli L, Beltramo G et al. Linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer. Radiother Oncol 2009;93:14-17.
49. Kim MS, Yoo SY, Cho CK et al. Stereotactic body radiotherapy for isolated para-aortic lymph node recurrence after curative resection in gastric cancer. J Korean Med Sci 2009;24:488-492.
50. Kim MS, Cho CK, Yang KM et al. Stereotactic body radiotherapy for isolated paraaortic lymph node recurrence from colorectal cancer. World J Gastroenterol 2009;15:6091-6095.
51. Bignardi M, Navarria P, Mancosu P et al. Clinical outcome of hypofractionated stereotactic radiotherapy for abdominal lymph node metastases. Int J Radiat Oncol Biol Phys 2011;81:831-838.
52. Lam KY, Lo CY. Metastatic tumours of the adrenal glands: A 30-year experience in a teaching hospital. Clin Endocrinol (Oxf) 2002;56:95-101.
53. Duh QY. Resecting isolated adrenal metastasis: Why and how? Ann Surg Oncol 2003;10:1138-1139.
54. Holy R, Piroth M, Pinkawa M et al. Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer. Strahlenther Onkol 2011;187:245-251.
55. Torok J, Wegner RE, Burton SA et al. Stereotactic body radiation therapy for adrenal metastases: A retrospective review of a noninvasive therapeutic strategy. Future Oncol 2011;7:145-151.
56. Sahgal A, Bilsky M, Chang EL et al. Stereotactic body radiotherapy for spinal metastases: Current status, with a focus on its application in the postoperative patient. J Neurosurg Spine 2011;14.151-166.
57. Gagnon GJ, Henderson FC, Gehan EA et al. Cyberknife radiosurgery for breast cancer spine metastases: A matched-pair analysis. Cancer 2007;110:1796-1802.
58. Chang EL, Shiu AS, Mendel E et al. Phase I/II study of stereotactic body radiotherapy for spinal metastases and its pattern of failure. J Neurosurg Spine 2007;7:151-160.
59. Rosenthal D, Callstrom MR. Critical review and state of the art in interventional oncology: Benign and metastatic disease involving bone. Radiology 2012;262: 765-780.
60. Goetz MP, Callstrom MR, Charboneau JW et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: A multicenter study. J Clin Oncol 2004;22:300-306.
61. Dupuy DE, Liu D, Hartfeil D et al. Percutaneous radiofrequency ablation of painful osseous metastases: A multicenter American College of Radiology Imaging Network trial. Cancer 2010;116:989-997.
62. Yabroff KR, Davis WW, Lamont EB et al. Patient time costs associated with cancer care. J Natl Cancer Inst 2007;99:14-23.
63. American Cancer Society. Cancer Facts & Figures 2010. Available at http://www.cancer.org/acs/groups/ content/@epidemiologysurveilance/documents/document/ acspc-026238.pdf, accessed January 1, 2011.
64. Sullivan R, Peppercorn J, SikoraKet al. Delivering affordable cancer care in high-income countries. Lancet Oncol 2011;12:933-980.
65. Sher DJ, Wee JO, Punglia RS. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2011;81:e767-e774.
66. Thariat J, Marcy PY, Lagrange JL. [Trends in radiation therapy for the treatment of metastatic and oligometastatic disease in 2010.] Bull Cancer 2010;97:1467-1476. In French.
67. Timmerman RD, Kavanagh BD, Cho LC et al. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 2007;25:947-952.
68. Treasure T. Pulmonary metastasectomy: A common practice based on weak evidence. Ann R Coll Surg Engl 2007;89:744-748.
69. Fiorentino F, Hunt I, Teoh K et al. Pulmonary metastasectomy in colorectal cancer: A systematic review and quantitative synthesis. J R Soc Med 2010;103:60-66.
70. ClinicalTrials. gov. Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET). Available at http:// clinicaltrials.gov/ct2/show/NCT01446744, accessed June 13, 2012.
71. Yoon SM, Choi EK, Lee SW et al. Clinical results of stereotactic body frame based fractionated radiation therapy for primary or metastatic thoracic tumors. Acta Oncol 2006;45:1108-1114.
72. Brown WT, Wu X, Fowler JF et al. Lung metastases treated by CyberKnife image-guided robotic stereotactic radiosurgery at 41 months. South Med J 2008;101: 376-382.
73. Yamada Y, Bilsky MH, Lovelock DM et al. Highdose single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys 2008;71:484-490.
74. Ryu S, Fang Yin F, Rock J et al. Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis. Cancer 2003;97:2013-2018.
75. Nguyen QN, Shiu AS, Rhines LD et al. Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2010;76:1185-1192.
76. Tsai JT, Lin JW, Chiu WT et al. Assessment of image-guided CyberKnife radiosurgery for metastatic spine tumors. J Neuroncol 2009;94:119-127.
77. Gibbs IC, Kamnerdsupaphon P, Ryu MR et al. Image-guided robotic radiosurgery for spinal metastases. Radiother Oncol 2007;82:185-190.
78. Gerszten PC, Burton SA, Ozhasoglu C et al. Radiosurgery for spinal metastases: Clinical experience in 500 cases from a single institution. Spine 2007;32:193-199.